Tools

LEADER 03815cam 22005537a 4500

001 ssj0000645747;

003 WaSeSS;

005 20230912080512.0;

006 m d ;

007 cr n ;

008 120518s2012 dcua sb 100 0 eng d;

010 a| 2011278592;

020 a| 9780309220644;

020 a| 0309220645;

035 a| (WaSeSS)ssj0000645747;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| RC268b| .N384 2011;

245 10 a| Facilitating collaborations to develop combination investigational cancer therapiesh| [electronic resource] :b| workshop summary /c| Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.;

260 a| Washington, D.C. :b| National Academies Press,;

300 a| xiii, 103 p. :b| ill. ;c| 23 cm.;

500 a| Workshop entitled "Facilitating collaborations to develop combination investigational cancer therapies" was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.;

504 a| Includes bibliographical references (p. 97-99).;

505 1 a| Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms.;

506 a| Available only to authorized users.;

520 a| "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description.;

530 a| Also available online.;

538 a| Mode of access: World Wide Web;

650 0 a| Cancerx| Treatmentv| Congresses.=| ^A1022808;

650 0 a| Health planningz| United Statesv| Congresses.=| ^A58;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Patlak, Margie.=| ^A1015055;

700 1 a| Nass, Sharyl J.=| ^A875025;

700 1 a| Balogh, Erin.=| ^A1108144;

710 2 a| Institute of Medicine (U.S.).b| Board on Health Care Services.=| ^A881507;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=3378946;

947 a| (OCoLC)ocn779347196;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 4075866;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4075866-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 1/1/2016x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4075866-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 1/1/2016x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4075866-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 1/1/2016x| EBOOKz| JERESOURCE;

Facilitating collaborations to develop combination investigational cancer therapies workshop summary / Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

Author/creator	National Cancer Policy Forum (U.S.).
Format	Electronic
Publication Info	Washington, D.C. : National Academies Press,
Description	xiii, 103 p. : ill. ; 23 cm.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Cancer--Research. --United States. --Congresses. Cancer--Treatment. --Congresses. Cancer--United States. --Prevention. --Congresses. Health planning--United States. --Congresses.

Other author/creator	Patlak, Margie.
Other author/creator	Nass, Sharyl J.
Other author/creator	Balogh, Erin.
Other author/creator	Institute of Medicine (U.S.). Board on Health Care Services.
Incomplete content	Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms.
Abstract	"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description.
General note	Workshop entitled "Facilitating collaborations to develop combination investigational cancer therapies" was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.
Bibliography note	Includes bibliographical references (p. 97-99).
Access restriction	Available only to authorized users.
Other forms	Also available online.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2011278592
ISBN	9780309220644
ISBN	0309220645

Facilitating collaborations to develop combination investigational cancer therapies workshop summary / Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

Click here for more information about this title